Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging drugs for psoriatic arthritis.
Caso F, Del Puente A, Peluso R, Caso P, Girolimetto N, Del Puente A, Scarpa R, Costa L. Caso F, et al. Among authors: caso p. Expert Opin Emerg Drugs. 2016;21(1):69-79. doi: 10.1517/14728214.2016.1146679. Epub 2016 Feb 15. Expert Opin Emerg Drugs. 2016. PMID: 26807876 Review.
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U, Lubrano E, Peluso R, Caso P, Galeazzi M, Punzi L, Scarpa R, Costa L. Caso F, et al. Among authors: caso p. Expert Opin Biol Ther. 2015 May;15(5):641-50. doi: 10.1517/14712598.2015.1011616. Epub 2015 Feb 4. Expert Opin Biol Ther. 2015. PMID: 25652590 Review.
Small molecule therapy for managing moderate to severe psoriatic arthritis.
Costa L, Del Puente A, Peluso R, Tasso M, Caso P, Chimenti MS, Sabbatino V, Girolimetto N, Benigno C, Bertolini N, Del Puente A, Perricone R, Scarpa R, Caso F. Costa L, et al. Among authors: caso p, caso f. Expert Opin Pharmacother. 2017 Oct;18(15):1557-1567. doi: 10.1080/14656566.2017.1378343. Epub 2017 Sep 18. Expert Opin Pharmacother. 2017. PMID: 28891341 Review.
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V, Frediani B, Cimaz R, Marrani E, Nieves-Martín L, Atteno M, Raffaele CG, Tarantino G, Galeazzi M, Punzi L, Cantarini L. Caso F, et al. Among authors: caso p. Mediators Inflamm. 2014;2014:107421. doi: 10.1155/2014/107421. Epub 2014 Jun 30. Mediators Inflamm. 2014. PMID: 25061259 Free PMC article. Review.
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
Peluso R, Caso F, Tasso M, Ambrosino P, Dario Di Minno MN, Lupoli R, Criscuolo L, Caso P, Ursini F, Puente AD, Scarpa R, Costa On Behalf Of CaRRDs Study Group L. Peluso R, et al. Among authors: caso p, caso f. Rev Recent Clin Trials. 2018;13(3):199-209. doi: 10.2174/1574887113666180314105511. Rev Recent Clin Trials. 2018. PMID: 29542417 Free PMC article.
From autoinflammation to autoimmunity: old and recent findings.
Caso F, Costa L, Nucera V, Barilaro G, Masala IF, Talotta R, Caso P, Scarpa R, Sarzi-Puttini P, Atzeni F. Caso F, et al. Among authors: caso p. Clin Rheumatol. 2018 Sep;37(9):2305-2321. doi: 10.1007/s10067-018-4209-9. Epub 2018 Jul 16. Clin Rheumatol. 2018. PMID: 30014358 Review.
205 results